An evidence-based microscopic hematuria care pathway optimizes decision-making among providers
- 15 October 2022
- journal article
- research article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 34 (7) , 1447-1451
Abstract
Introduction and hypothesis Microscopic hematuria (MH) has many etiologies in women and requires specific gynecologic evaluation. We created a standardized MH pathway to serve as an evidence-based decision aid for providers in our practice. Methods Using a modified Delphi process, a multidisciplinary team reviewed existing guidelines for MH diagnosis and treatment to reach consensus on care pathway components. Results Entry into the care pathway by an advanced practice provider is determined by the finding of ≥3 red blood cells per high-power field (RBC/HPF) on microscopic urinalysis. Initial evaluation includes history and physical exam. If there are signs of a gynecologic cause of MH, the conditions are treated and repeat urinalysis is performed in 6 months. If repeat urinalysis shows persistent MH or there are no other apparent causes for MH, we proceed with risk stratification. Through shared decision-making, low-risk patients may undergo repeat urinalysis in 6 months or cystoscopy with urinary tract ultrasound. For intermediate-risk patients, cystoscopy and urinary tract ultrasound are recommended. For high-risk patients, cystoscopy and axial upper urinary tract imaging are recommended. If evaluation is positive, urology referral is provided. If evaluation is negative, low-risk patients are released from care, but intermediate-risk or high-risk patients undergo repeat urinalysis in 12 months. If repeat urinalysis is positive, shared decision-making is used to determine a plan. Conclusions We developed an MH care pathway to standardize care of women with MH across a multidisciplinary group. This pathway serves as a component of value-based care and supports evidence-based care by providers.Keywords
This publication has 16 references indexed in Scilit:
- Risk Factors for Microscopic Hematuria in WomenUrogynecology, 2016
- Microhematuria in Postmenopausal Women: Adherence to Guidelines in a Tertiary Care SettingJournal of Urology, 2016
- The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapseInternational Urogynecology Journal, 2014
- Care pathways lead to better teamwork: Results of a systematic reviewSocial Science & Medicine, 2012
- The impact of overactive bladder on mental health, work productivity and health‐related quality of life in the UK and Sweden: results from EpiLUTSBJU International, 2011
- Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costsCochrane Database of Systematic Reviews, 2010
- The role of estrogens in female lower urinary tract dysfunctionUrology, 2003
- Microscopic HematuriaNew England Journal of Medicine, 2003
- Cellular proliferation in the female lower urinary tract with reference to oestrogen statusBJOG: An International Journal of Obstetrics & Gynaecology, 2001
- Integrated care pathwaysBMJ, 1998